Replimune Group REPL Income Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $222.84M+25.9% | $217.7M+26.7% | $203.27M+14.5% | $188.4M+7.7% | $177M+3.9% | ||
| $103.07M+60.9% | $102.36M+71.4% | $91.42M+55.0% | $73.23M+22.4% | $64.06M+9.2% | ||
| $325.91M+35.2% | $320.06M+38.2% | $294.69M+24.6% | $261.63M+11.4% | $241.06M+5.3% | ||
| -$325.91M-35.2% | -$320.06M-38.2% | -$294.69M-24.6% | -$261.63M-11.4% | -$241.06M-5.3% | ||
| $5.89M+2.8% | $5.87M+11.0% | $5.82M+21.2% | $5.78M+28.4% | $5.73M+39.6% | ||
| $10.64M-20.2% | $10.27M-45.9% | $14.94M-10.5% | $14.8M-23.7% | $13.33M-32.8% | ||
| —— | —— | —— | -$246.83M-14.6% | -$227.73M-8.9% | ||
| —— | —— | —— | —— | —— | ||
| -$314.85M-37.9% | -$310.26M-45.6% | -$280.22M-27.4% | -$247.3M-14.6% | -$228.24M-8.7% | ||
| -$3.44-12.1% | -$3.46-13.4% | -$3.24+0.9% | -$3.07+5.2% | -$3.07+2.8% | ||
| -$322.59M-35.7% | -$316.54M-38.5% | -$291.06M-24.6% | -$258.15M-11.2% | -$237.72M-5.0% | ||
| -$325.91M-35.2% | -$320.06M-38.2% | -$294.69M-24.6% | -$261.63M-11.4% | -$241.06M-5.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Replimune Group profitable?
- Replimune Group is not currently profitable: it reported a net loss of $314.9M over the trailing twelve months.
- What is Replimune Group's earnings per share?
- Replimune Group's diluted EPS over the trailing twelve months is $-3.44.
- Where does Replimune Group's income statement data come from?
- Every line is extracted from Replimune Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.